Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | TAK | ZTS | ONC | UTHR |
| Company | Akebia Therapeutics | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Beone Medicines Ltd | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.4100 | 17.92 | 116.51 | 285.31 | 533.83 |
| High | 1.5200 | 17.96 | 117.32 | 288.45 | 543.37 |
| Low | 1.4001 | 17.74 | 114.47 | 283.04 | 533.83 |
| Latest | 1.4600 | 17.77 | 115.62 | 284.05 | 536.12 |
| Change | +0.0600 | unch | +0.16 | -1.25 | +3.30 |
| % Change | +4.29% | unch | +0.14% | -0.44% | +0.62% |
| Volume | 3,751,000 | 2,500,300 | 3,783,200 | 229,100 | 544,800 |
| 20-Day Average Volume | 3,273,910 | 2,593,815 | 4,019,670 | 288,075 | 570,835 |
| Previous Close | 1.4000 | 17.77 | 115.46 | 285.30 | 532.82 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2710 | 18.31 | 124.99 | 324.41 | 501.06 |
| 20-Day Raw Stochastic | 84.21% | 19.85% | 6.45% | 1.13% | 85.39% |
| 20-Day Relative Strength | 55.19 | 51.93 | 35.20 | 33.87 | 60.52 |
| Weighted Alpha | -44.09 | +24.77 | -30.66 | +1.80 | +66.69 |
| Today's Opinion | 64% Sell | 80% Buy | 100% Sell | 24% Sell | 100% Buy |
| Previous Opinion | 72% Sell | 80% Buy | 100% Sell | 24% Sell | 100% Buy |
| Last Month's Opinion | 64% Sell | 100% Buy | 40% Sell | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.96% since 03/06/26 | -0.62% since 03/06/26 | -4.78% since 03/06/26 | -5.67% since 03/06/26 | +12.12% since 03/06/26 |
| Low | 1.2550 on 03/09/26 | 17.73 on 03/09/26 | 114.47 on 03/13/26 | 283.04 on 03/13/26 | 495.50 on 03/09/26 |
| High | 1.5200 on 03/13/26 | 18.34 on 03/10/26 | 122.96 on 03/10/26 | 308.99 on 03/10/26 | 548.12 on 03/10/26 |
| 1-Month | |||||
| %Chg | +20.66% since 02/13/26 | -3.74% since 02/13/26 | -8.71% since 02/13/26 | -17.92% since 02/13/26 | +13.19% since 02/13/26 |
| Low | 1.1400 on 02/20/26 | 17.51 on 03/03/26 | 114.47 on 03/13/26 | 283.04 on 03/13/26 | 466.00 on 02/23/26 |
| High | 1.5200 on 03/13/26 | 18.82 on 02/23/26 | 132.30 on 02/27/26 | 372.73 on 02/24/26 | 548.12 on 03/10/26 |
| 3-Month | |||||
| %Chg | -12.05% since 12/12/25 | +24.01% since 12/12/25 | -2.56% since 12/12/25 | -10.97% since 12/12/25 | +8.53% since 12/12/25 |
| Low | 1.1400 on 02/20/26 | 14.40 on 12/15/25 | 114.47 on 03/13/26 | 283.04 on 03/13/26 | 455.63 on 01/20/26 |
| High | 1.7300 on 12/22/25 | 18.82 on 02/23/26 | 132.49 on 02/12/26 | 372.73 on 02/24/26 | 548.12 on 03/10/26 |
| 6-Month | |||||
| %Chg | -50.51% since 09/12/25 | +17.68% since 09/12/25 | -21.98% since 09/12/25 | -12.42% since 09/12/25 | +32.37% since 09/12/25 |
| Low | 1.1400 on 02/20/26 | 12.99 on 10/30/25 | 114.47 on 03/13/26 | 283.04 on 03/13/26 | 396.12 on 09/15/25 |
| High | 3.2000 on 10/28/25 | 18.82 on 02/23/26 | 149.75 on 09/15/25 | 385.22 on 11/17/25 | 548.12 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 391,103 | 56,547,020 | 48,806,440 | 31,149,776 | 23,497,062 |
| Shares Outstanding, K | 267,879 | 3,182,162 | 422,128 | 109,663 | 43,828 |
| Annual Sales | 236,200,000 | 30,238,240,000 | 9,467,000,000 | 5,343,030,000 | 3,182,700,000 |
| Annual Net Income | -5,350,000 | 712,320,000 | 2,673,000,000 | 286,930,000 | 1,334,700,000 |
| Last Quarter Sales | 57,620,000 | 7,736,500,000 | 2,387,000,000 | 1,498,170,000 | 790,200,000 |
| Last Quarter Net Income | -12,240,000 | 672,830,000 | 603,000,000 | 66,500,000 | 364,300,000 |
| 60-Month Beta | 0.39 | 0.01 | 0.95 | 0.53 | 0.84 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 11/10/25 | 0.44 on 10/30/25 | 1.48 on 02/12/26 | 1.95 on 02/26/26 | 7.70 on 02/25/26 |
| Latest Earnings Date | 05/14/26 | 05/14/26 | 05/05/26 | 05/06/26 | 04/29/26 |
| Most Recent Dividend | N/A | 0.252 on 09/30/25 | 0.530 on 01/20/26 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 09/30/25 | 04/20/26 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.11 | 18.01 | 76.15 | 19.22 |